Histanaz 60 mg/1
Pseudoephedrine HCL, Pyrilamine Maleate · TABLET · Capital Pharmaceutical, LLC
Histanaz is a tablet containing pseudoephedrine hcl, pyrilamine maleate at 60 mg/1, taken oral. Manufactured by Capital Pharmaceutical, LLC.
Key Facts
- Brand Name
- Histanaz
- Generic Name
- Pseudoephedrine HCL, Pyrilamine Maleate
- NDC Code (Product)
29978-129- Manufacturer
- Capital Pharmaceutical, LLC
- Strength
- 60 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- M012
- Marketing Start
- 09/08/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Histanaz used for?
Histanaz contains Pseudoephedrine HCL, Pyrilamine Maleate. It is a tablet taken oral. Consult your doctor for specific uses.
Is Histanaz a controlled substance?
Histanaz is not classified as a controlled substance by the DEA.
What is the generic name for Histanaz?
The generic name for Histanaz is Pseudoephedrine HCL, Pyrilamine Maleate. There are no other listed brand versions of Pseudoephedrine HCL, Pyrilamine Maleate.
What is the NDC code for Histanaz 60 mg/1?
The NDC (National Drug Code) for Histanaz 60 mg/1 is 29978-129, listed by Capital Pharmaceutical, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)